Skip to content

Study · Non-randomized trial · 1984

2 results

Vasopressin analog (DDAVP) improves memory in human males.

Beckwith BE, Till RE, Schneider V

Peptides1 Jul 1984Cited by 37 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In healthy young adult men, DDAVP improved memory for implicational sentences versus controls.

    In plain wordsIn healthy young men, DDAVP improved sentence memory compared with controls.

    Outcome
    Direction not reportedMemory for implicational sentences in men
    Study

    n: not reported in source

    Comparator
    Control subjects
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Healthy young male adult subjects treated with DDAVP demonstrated better memory for implicational sentences than did control subjects.
  2. 02HumanNon-randomized trialEfficacy outcome

    In women, DDAVP had no influence on the same memory task.

    In plain wordsIn women, DDAVP did not affect the same memory task.

    Outcome
    No significant changeMemory task in women
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The same treatment had no influence on women given the same memory task.
    1 context sentence
    Summary · context
    Healthy young male adult subjects treated with DDAVP demonstrated better memory for implicational sentences than did control subjects.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.